Pulmonx Corp

Healthcare · Medical Devices · —

1.90$ +2.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Pulmonx Corp (LUNG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 115 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LUNG
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	0.6	2.1	3.7	2.7	1.5	–	–	–	54	–	67	71	264	255	249	247	235	223	213	202	194	201	193	185	178	165	173	167	163	151	147	138	129	120	115
Current Assets	0.0	1.6	3.2	2.1	1.0	4.1	–	–	41	28	56	56	250	239	233	228	208	201	193	183	169	181	164	147	150	148	146	141	136	124	120	111	102	93	88
Cash	0.0	1.5	3.0	1.8	0.6	-4.1	–	–	15	-28	44	40	232	210	199	188	148	129	122	113	102	111	102	95	84	70	63	63	71	75	75	77	70	62	56
Cash & Short-Term Investments	–	–	–	–	–	4.1	–	–	28	28	44	40	232	219	210	200	180	170	162	157	141	153	136	117	117	116	115	108	101	89	84	77	70	62	56
Receivables	–	–	–	–	–	–	–	–	6.0	–	3.2	5.5	4.6	5.4	7.3	7.3	6.9	6.8	7.5	7.7	9.4	9.0	10	11	13	11	12	12	14	15	16	14	12	11	12
Inventory	–	–	–	–	–	–	–	–	5.6	–	8.4	9.3	11	12	13	15	16	18	19	16	15	16	16	16	17	17	17	17	17	17	16	16	16	16	16
Property, Plant & Equipment	0.1	0.4	0.3	0.4	0.3	–	–	–	–	–	7.7	11	10	10	11	13	13	4.9	12	11	5.3	4.5	4.2	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	2.3	–	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3
Intangible Assets	0.2	0.2	0.2	0.2	0.2	–	–	–	0.5	–	0.5	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	–	–	–	–	–	–	–	0.7	0.7	–
Total Liabilities	3.4	1.7	1.5	1.5	1.5	–	–	–	241	–	272	71	38	39	39	44	42	41	41	39	40	57	59	59	59	54	71	73	77	73	78	78	75	74	76
Current Liabilities	0.8	0.3	0.3	0.3	0.3	–	–	–	14	–	8.9	15	13	14	16	22	18	18	20	22	18	17	20	20	23	21	16	18	24	25	22	23	20	19	20
Short-Term Debt	2.8	1.4	0.1	1.2	–	–	–	–	0.4	–	1.3	1.9	2.2	2.2	3.6	5.3	2.3	6.7	9.0	8.2	3.3	3.4	3.4	3.5	5.2	7.9	1.2	1.4	4.0	8.9	1.2	1.2	1.3	1.3	1.4
Accounts Payable	0.4	0.3	0.2	0.3	0.3	–	–	–	2.7	–	1.0	2.3	1.5	1.8	2.2	4.4	1.6	2.8	2.6	2.6	1.8	2.9	2.4	3.2	1.5	3.1	3.2	4.6	3.8	4.3	6.6	6.4	3.9	3.5	4.7
Long-Term Debt	2.7	1.4	1.2	1.2	1.2	–	–	–	15	–	17	47	17	17	15	14	17	17	14	12	17	37	37	37	35	32	37	37	34	29	37	37	37	37	37
Shareholders' Equity	-2.8	0.4	2.2	1.2	-0.1	-27	–	–	-187	18	-206	0.7	226	217	210	203	193	182	172	163	154	144	134	126	118	110	101	94	86	78	69	60	54	46	39
Retained Earnings	-16	-17	-18	-20	-21	–	–	–	-211	–	-230	-233	-243	-255	-267	-278	-291	-307	-322	-336	-350	-366	-382	-397	-411	-425	-440	-454	-468	-482	-497	-511	-522	-535	-545
Shares Outstanding	–	–	–	–	–	1.7	1.7	21	21	21	31	34	34	35	36	36	37	37	37	37	37	38	38	38	38	39	39	39	39	40	40	41	41	42	42

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings